Today's Low
₹ 22.05
Today's High
₹ 24.00
52 Weeks Low
₹ 6.60
52 Weeks High
₹ 14.50
Lower
₹ 22.05
Upper
₹ 24.35
Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|
Total Current Assets | 186.1 | 206.4 | 611.7 |
Total Non-Current Assets | 428.6 | 458.1 | 433.3 |
Total Assets | 614.8 | 664.6 | 1,054.8 |
Total Current Liabilities | 598.2 | 607.9 | 620.9 |
Total Non-Current Liabilities | 679.7 | 672.2 | 679.3 |
Shareholder's Funds | -663.2 | -615.5 | -245.4 |
Total Liabilities | 614.8 | 664.6 | 1,054.8 |
The Industry Current Ratio stands at 2.28, vs the Current Ratio of 0.34, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.39, vs the Debt to Equity Ratio of -1.70, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.59, vs the Quick Ratio of 0.28, which results in a Negative aspect.
The Industry Price to BV stands at 6.12, vs the Price to BV of -0.17, which results in a Negative aspect.
Particulars | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|
Total Income | 269.8 | 263.1 | 304.3 |
Total Expenditure | 263.5 | 328.5 | 461.3 |
Operating Profit(Excl OI) | 20.9 | -51.7 | -144.5 |
Add: Other Income | 14.6 | 13.7 | 12.5 |
Operating Profit | 20.9 | -51.7 | -144.5 |
Less: Interest | 11.5 | 16.3 | 19.0 |
PBDT | 9.4 | -68.0 | -163.4 |
Less: Depreciation Amortization | 34.6 | 35.7 | 36.4 |
PBT & Exceptional Items | -25.2 | -103.8 | -199.8 |
Less: Exceptional Income Expenses | -28.2 | -259.6 | 0.0 |
Profit Before Tax | -53.4 | -363.4 | -199.8 |
Less: Taxation | 0.8 | 0.9 | 0.2 |
Profit After Tax | -54.1 | -364.3 | -199.9 |
Earnings Per Share | -0.1 | -0.7 | -0.4 |
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 10.64, vs the PAT Margin of -136.33, which results in a Negative aspect.
The Industry PE Ratio stands at 43.30, vs the PE Ratio of 4.08, which results in a Negative aspect.
The Industry PAT Growth stands at 10.05, vs the PAT Growth of -82.19, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Profit Before Tax | -34.5 | -20.3 | -50.4 | -371.8 | -213.4 |
Tax Paid | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 |
Adjustment | 85.2 | 77.9 | 73.9 | 321.1 | 168.5 |
Changes In Working Capital | -34.5 | -20.3 | -50.4 | -371.8 | -213.4 |
Cash Flow after changes in Working Capital | 73.0 | 50.6 | 7.2 | -1.7 | -119.4 |
Cash Flow from Operating Activities | 73.0 | 50.2 | 7.2 | -1.7 | -119.4 |
Cash Flow from Investing Activities | -29.3 | -18.4 | -6.4 | 4.1 | 9.6 |
Cash Flow from Financing Activities | -46.6 | -44.6 | -6.2 | -10.7 | 110.2 |
Net Cash Inflow / Outflow | -2.9 | -12.8 | -5.4 | -8.3 | 0.4 |
Opening Cash & Cash Equivalents | 16.2 | 29.0 | 9.1 | 17.4 | 17.0 |
Closing Cash & Cash Equivalent | 13.3 | 16.2 | 3.7 | 9.1 | 17.4 |
The Industry PFCF Ratio stands at -23.23, vs the PFCF Ratio of -0.11, which results in a Positive aspect.
The Industry PCF RATIO stands at 20.75, vs the PCF RATIO of -17.69, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
---|---|---|---|---|---|---|---|
Net Sales | 1,025.6 | 1,159.2 | 1,485.4 | 1,058.8 | 1,065.9 | 1,038.2 | 946.8 |
Total Income | 1,051.8 | 1,190.7 | 1,541.7 | 1,121.6 | 1,097.9 | 1,048.2 | 961.8 |
Total Expenditure | 980.7 | 1,047.8 | 1,301.4 | 979.3 | 886.9 | 929.0 | 895.5 |
PBIDT (Excl OI) | 44.9 | 111.4 | 184.0 | 79.5 | 178.9 | 109.2 | 51.3 |
Other Income | 26.2 | 31.5 | 56.3 | 62.8 | 32.0 | 10.0 | 15.1 |
Operating Profit | 71.1 | 142.9 | 240.3 | 142.3 | 211.0 | 119.3 | 66.3 |
Interest | 153.0 | 182.7 | 149.5 | 144.8 | 148.4 | 153.8 | 150.6 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 605.8 | 0.0 | 0.0 | 0.0 |
PBDT | -81.9 | -39.7 | 90.8 | 603.3 | 62.6 | -34.6 | -84.3 |
Depreciation | 67.8 | 67.3 | 67.2 | 72.4 | 72.9 | 71.4 | 70.1 |
Profit Before Tax | -149.7 | -107.1 | 23.6 | 531.0 | -10.3 | -105.9 | -154.4 |
Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | -149.7 | -107.1 | 23.6 | 531.0 | -10.3 | -105.9 | -154.4 |
Net Profit | -149.7 | -107.1 | 23.6 | 531.0 | -10.3 | -105.9 | -154.4 |
ADDITIONAL INFOS: | |||||||
Equity Capital | 108.3 | 108.3 | 108.3 | 108.3 | 108.3 | 108.3 | 108.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | -2.8 | -2.0 | 0.4 | 9.8 | -0.2 | -2.0 | -2.9 |
Operating Profit Margin | 6.9 | 12.3 | 16.2 | 13.4 | 19.8 | 11.5 | 7.0 |
Net Profit Margin | -14.6 | -9.2 | 1.6 | 50.1 | -1.0 | -10.2 | -16.3 |
The Industry Mcap Growth stands at 1.96, vs the Mcap Growth of 12.17, which results in a Positive aspect.
The Industry Net Sales Growth stands at 8.33, vs the Net Sales Growth of -13.56, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 26.10 | 28.46 | 23.27 |
R3 | 25.40 | 25.13 | 22.74 |
R2 | 24.70 | 24.56 | 22.56 |
R1 | 23.45 | 23.18 | 22.38 |
Pivot | 22.75 | 22.61 | 22.75 |
S1 | 21.50 | 21.23 | 22.02 |
S2 | 20.80 | 20.66 | 21.84 |
S3 | 19.55 | 19.28 | 21.66 |
S4 | 18.30 | 16.76 | 21.13 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
29.01
Neutral
RSI
51.95
Neutral
ROC
21.64
Bullish
UltimateOscillator
28.44
Bearish
Williams Indicator
-60.61
Neutral
CCI Indicator
24.32
Neutral
MACD
-2,917.43
Bearish
Stochastic Indicator
41.64
Neutral
ATR
1.98
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
14-02-2024 | Quarterly Results (Revised) |
13-02-2024 | Quarterly Results |
09-11-2023 | Quarterly Results |
10-08-2023 | Quarterly Results |
30-05-2023 | Audited Results |
13-02-2023 | Quarterly Results |
14-11-2022 | Quarterly Results |
09-08-2022 | Quarterly Results |
30-05-2022 | Audited Results |
14-02-2022 | Quarterly Results |
13-11-2021 | Quarterly Results |
14-08-2021 | Quarterly Results |
28-06-2021 | Audited Results |